Brett Sandercock is Chief Financial Officer of RESMED INC. Currently has a direct ownership of 92,056 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on May 08, 2024, when has been sold 13,000 shares (ResMed Common Stock) at a price of $211.37 per share, resulting in proceeds of $2,747,810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.1K
0.97% 3M change
1.22% 12M change
Total Value Held $0

Brett Sandercock Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2024
SELL
Open market or private sale
$2,747,810 $211.37 p/Share
13,000 Reduced 12.37%
92,056 ResMed Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
$1,219,680 $101.64 p/Share
12,000 Added 10.25%
105,056 ResMed Common Stock
Nov 27 2023
SELL
Open market or private sale
$457,860 $152.62 p/Share
3,000 Reduced 3.13%
92,962 ResMed Common Stock
Aug 17 2023
BUY
Grant, award, or other acquisition
-
4,972 Added 4.93%
95,915 ResMed Common Stock
May 10 2023
SELL
Open market or private sale
$2,931,376 $233.13 p/Share
12,574 Reduced 12.15%
90,942 ResMed Common Stock
May 09 2023
SELL
Open market or private sale
$795,003 $232.05 p/Share
3,426 Reduced 3.2%
103,516 ResMed Common Stock
Feb 17 2023
SELL
Open market or private sale
$2,152,200 $215.22 p/Share
10,000 Reduced 8.56%
106,880 ResMed Common Stock
Feb 13 2023
SELL
Open market or private sale
$860,000 $215.0 p/Share
4,000 Reduced 3.31%
116,880 ResMed Common Stock
Nov 23 2022
BUY
Grant, award, or other acquisition
-
14,577 Added 10.76%
120,880 ResMed Common Stock
Nov 07 2022
SELL
Open market or private sale
$848,080 $212.02 p/Share
4,000 Reduced 3.63%
106,303 ResMed Common Stock
Aug 18 2022
BUY
Grant, award, or other acquisition
-
3,847 Added 3.37%
110,273 ResMed Common Stock
Aug 10 2022
SELL
Open market or private sale
$601,650 $240.66 p/Share
2,500 Reduced 2.3%
106,426 ResMed Common Stock
Aug 10 2022
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.24%
108,926 ResMed Common Stock
Jul 22 2022
SELL
Open market or private sale
$1,762,500 $235.0 p/Share
7,500 Reduced 6.58%
106,426 ResMed Common Stock
Jul 22 2022
BUY
Exercise of conversion of derivative security
$433,200 $57.76 p/Share
7,500 Added 6.18%
113,926 ResMed Common Stock
Apr 11 2022
SELL
Open market or private sale
$617,500 $247.0 p/Share
2,500 Reduced 2.3%
106,354 ResMed Common Stock
Apr 11 2022
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.25%
108,854 ResMed Common Stock
Mar 10 2022
SELL
Open market or private sale
$603,225 $241.29 p/Share
2,500 Reduced 2.3%
106,354 ResMed Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.25%
108,854 ResMed Common Stock
Feb 10 2022
SELL
Open market or private sale
$604,650 $241.86 p/Share
2,500 Reduced 2.3%
106,354 ResMed Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.25%
108,854 ResMed Common Stock
Jan 10 2022
SELL
Open market or private sale
$587,500 $235.0 p/Share
2,500 Reduced 2.3%
106,354 ResMed Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.25%
108,854 ResMed Common Stock
Dec 10 2021
SELL
Open market or private sale
$662,300 $264.92 p/Share
2,500 Reduced 2.3%
106,354 ResMed Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
$144,400 $57.76 p/Share
2,500 Added 2.25%
108,854 ResMed Common Stock
BS

Brett Sandercock

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on RSMDF

Follow RESMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

News

Receive news related to RESMED INC

Track Activities on RSMDF